Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05808933

Magnetic Resonance Fingerprinting for Preoperative Evaluation of Lymphovascular Space Invasion in Early Stage Cervical Cancer

The aim of this observational prospective study is to investigate the role of Magnetic Resonance Fingerprinting in preoperative assessment of early cervical cancer

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Cervical Cancer Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Genital Diseases Genital Diseases, Female Genital Neoplasms, Female Neoplasms Neoplasms by Site Urogenital Diseases Urogenital Neoplasms Uterine Cervical Diseases Uterine Cervical Neoplasms Uterine Diseases Uterine Neoplasms

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with biopsy-proven cervical cancer FIGO stage IA-IIA undergoing surgery;
  • Women aged >18 years old;
  • Signed Informed Consent.

Exclusion criteria

  • Concurrent malignancies at other sites;
  • Previous history of neoplasm;
  • Refusal to sign written informed consent

Treatment and study plan

Primary outcomes

  1. Association between T1-, T2- and ADC-maps and LVSI status

    Time frame: 3 months

Secondary outcomes

  1. Correlation between T1-, T2- and ADC-maps and DFS and OS

    Time frame: 3 years

  2. Correlation between Radiomics-based analysis and LVSI status and DFS and OS

    Time frame: 3 years

Study contacts

Contact information is provided by the study sponsor or research team.

Benedetta B Gui, MD

CONTACT

[email protected]

0630155464 ext. +39

Luca L Russo, MD

CONTACT

[email protected]

0630156054 ext. +39

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Acronym: MARF-ESC

Important dates

Study start
2022
Primary completion
2027
Study completion
2027
First posted
Apr 12, 2023
Registry last updated
Apr 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.